Results showed that anti-Jag1 antibodies did not prevent the IL-4-induced increase in Hes1 levels, suggesting that IL-4-induced Notch activation does not depend on the increased availability of Jag1 in CLL cells (Fig. 7a, b and Supplementary Figure S7A). Here, JAG1 is linked to B-cell chronic lymphocytic leukemia.